Table 3.
Predicted pharmacokinetics properties for druglikeliness of top ranked ligands.
Compound Name | Aqueous Solubility | Solubility class | BBB permeant | CYP2D6 inhibitor | P Glycoprotein substrate | GI absorption |
---|---|---|---|---|---|---|
Andrographolide | −3.18 | Soluble | No | No | Yes | High |
Hydro andrographolide | −3 | Soluble | No | No | Yes | High |
Iso andrographolide | −3.35 | Soluble | No | Yes | Yes | High |
Neo andrographolide | −4.01 | Moderately soluble | No | No | Yes | High |
Oxo andrographolide | −2.79 | Soluble | No | No | Yes | High |
Mulberroside A | −2.53 | Soluble | No | No | No | High |
Mulberroside C | −3.79 | Soluble | No | No | No | Low |
Mulberroside E | −2.66 | Soluble | No | No | No | Low |
Mulberroside F | −2.73 | Soluble | No | No | Yes | Low |
Mimusopic acid | −5.91 | Moderately soluble | No | No | No | High |
Nimbolide | −3.94 | Soluble | No | No | Yes | High |
Emblicanin A | −5.63 | Moderately soluble | No | No | Yes | Low |
Punigluconin | −5.17 | Moderately soluble | No | No | Yes | Low |
Chebulic acid | −1.39 | Soluble | No | No | No | Low |
Anolignan A | −5.17 | Moderately soluble | Yes | Yes | No | High |
Anolignan B | −5.07 | Moderately soluble | Yes | Yes | No | High |
Anolignan C | −4.28 | Moderately soluble | Yes | Yes | Yes | High |